Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0TMPMK
ADC Name
PHN-010
Synonyms
PHN 010; PHN-010; PHN010
   Click to Show/Hide
Organization
Pheon Therapeutics Ltd.
Drug Status
Phase 1
Indication
In total 6 Indication(s)
Cervical cancer
Phase 1
Clinical Trial
Colorectal cancer
Phase 1
Clinical Trial
Endometrial cancer
Phase 1
Clinical Trial
Lung cancer
Phase 1
Clinical Trial
Ovarian cancer
Phase 1
Clinical Trial
Solid tumor
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
8
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
DNA topoisomerase-I inhibitor
  Payload Info 
Therapeutic Target
DNA topoisomerase 1 (TOP1)
  Target Info 
Linker Name
Undisclosed
Conjugate Type
Undisclosed